|
Volumn 7, Issue 5, 2001, Pages 1378-1384
|
Frederine, a new and promising protector against doxorubicin-induced cardiotoxicity
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DOXORUBICIN;
FLAVONOID;
FREDERINE;
MONOXERUTIN;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ANTINEOPLASTIC ACTIVITY;
ANTIOXIDANT ACTIVITY;
ARTICLE;
BREAST CARCINOMA;
CARDIOTOXICITY;
CONTROLLED STUDY;
DRUG STRUCTURE;
HEART PROTECTION;
HUMAN;
HUMAN CELL;
MALE;
MOUSE;
NONHUMAN;
OVARY CARCINOMA;
PRIORITY JOURNAL;
ANALYSIS OF VARIANCE;
ANIMALS;
ANTIBIOTICS, ANTINEOPLASTIC;
ANTINEOPLASTIC AGENTS;
BODY WEIGHT;
CELL DIVISION;
DISEASE MODELS, ANIMAL;
DOXORUBICIN;
DRUG THERAPY, COMBINATION;
ELECTROCARDIOGRAPHY;
FEMALE;
FLAVONOIDS;
HEART;
HEART DEFECTS, CONGENITAL;
HUMANS;
MALE;
MICE;
MICE, INBRED BALB C;
OVARIAN NEOPLASMS;
PROTECTIVE AGENTS;
TUMOR CELLS, CULTURED;
XENOGRAFT MODEL ANTITUMOR ASSAYS;
|
EID: 0034895982
PISSN: 10780432
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (22)
|
References (33)
|